# Macular Pigment and Visual Performance in Glaucoma Patients

> **NCT03959592** · PHASE1,PHASE2 · TERMINATED · sponsor: **Felipe Medeiros, MD** · enrollment: 8 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Lutein, zeaxanthin and mesozeaxanthin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03959592
- **Lead sponsor:** Felipe Medeiros, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-08-21
- **Primary completion:** 2021-11-09
- **Final completion:** 2021-11-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Preliminary analysis showed no benefit of the investigational supplement.
- **Last updated:** 2023-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03959592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03959592, "Macular Pigment and Visual Performance in Glaucoma Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03959592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*